Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Asset Utilization Ratio (2023 - 2026)

TriSalus Life Sciences has reported Asset Utilization Ratio over the past 4 years, most recently at 0.84 for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio fell 30.91% year-over-year to 0.84; the TTM value through Mar 2026 reached 0.84, down 30.91%, while the annual FY2025 figure was 1.52, 25.65% up from the prior year.
  • Asset Utilization Ratio for Q1 2026 was 0.84 at TriSalus Life Sciences, down from 1.26 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.26 in Q4 2025 and troughed at 0.64 in Q4 2023.
  • A 4-year average of 0.97 and a median of 1.01 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: surged 79.72% in 2024 and later plummeted 30.91% in 2026.
  • Year by year, Asset Utilization Ratio stood at 0.64 in 2023, then surged by 79.72% to 1.14 in 2024, then increased by 9.94% to 1.26 in 2025, then plummeted by 32.87% to 0.84 in 2026.
  • Business Quant data shows Asset Utilization Ratio for TLSI at 0.84 in Q1 2026, 1.26 in Q4 2025, and 1.03 in Q3 2025.